Understanding and communicating key concepts in risk management: What do we mean by benefit and risk?

Drug Safety

Volumn 32, Issue 6, 2009, Pages 449-452

  Edwards, I Ralph ^a   Lindquist, Marie ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; MEDICAL ETHICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; RISK MANAGEMENT;

COMMUNICATION; HUMANS; PHARMACEUTICAL PREPARATIONS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RISK MANAGEMENT;

EID: 66249136719     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200932060-00001     Document Type: Editorial

References (7)

1. Lindquist M. The need for definitions in pharmacovigilance. Drug Saf 2007; 30 (10): 825-30
2. Hauben M, Aronson J. Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Safety 2009; 32 (2): 99-110
3. Bombardier C, Maetzel A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? Ann Rheum Dis 1999; 58 Suppl. 1:I82-5
4. Grimmer-Somers K, Vipond N, Kumar S, et al. A review and critique of assessment instruments for patients with persistent pain. J Pain Res 2009; 2: 21-47
5. Ware J. Methodological considerations in selection of health status assessment procedures. In: Wenger N, Mattson ME, Furberg CD, et al., editors. Assessment of quality of life in clinical trials of cardiovascular therapy. New York: LeJacq Publishing, 1984: 87-111
6. Wyith Institute of Technology. Traditional Chinese medicine basics [online]. Available from URL: http://www.tcmba sics.com/introduction.htm [Accessed 2009 May 4]
7. Edwards P. Homeopathy: patient-centred paradox, in anthropology. Dunedin: Otago University, 1986